Loading...

Development of siRNA payloads to target KRAS-mutant cancer

RNA interference (RNAi) is a powerful tool for target identification and can lead to novel therapies for pharmacologically intractable targets such as KRAS. RNAi therapy must combine potent siRNA payloads with reliable in vivo delivery for efficient target inhibition. We employed a functional “Senso...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Yuan, Tina L., Fellmann, Christof, Lee, Chih-Shia, Ritchie, Cayde D., Thapar, Vishal, Lee, Liam C., Hsu, Dennis J., Grace, Danielle, Carver, Joseph O., Zuber, Johannes, Luo, Ji, McCormick, Frank, Lowe, Scott W.
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184972/
https://ncbi.nlm.nih.gov/pubmed/25100204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0900
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!